Slingshot members are tracking this event:
Boehringer Ingelheim Announces Phase 3 Results for Humira Biosimilar Candidate in Active Rheumatoid Arthritis
Slingshot Insights Explained
Oct 26, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Active Rheumatoid Arthritis, Humira, Biosimilar, Phase 3, Results